Frailty modifications and prognostic impact in older patients admitted in acute care.


Journal

Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995

Informations de publication

Date de publication:
Jan 2019
Historique:
received: 22 02 2018
accepted: 11 06 2018
pubmed: 28 6 2018
medline: 14 3 2019
entrez: 28 6 2018
Statut: ppublish

Résumé

Frailty is a predictor of adverse outcomes in older subjects. The aims of this study are to (1) measure the frailty status and its changes occurring during the hospital stay, (2) determine the relationships among frailty and adverse outcomes. Frailty was assessed using a 46-item Frailty Index (FI) in 156 patients admitted to an Acute Geriatric Medicine Unit. The FI was calculated within 24 h from the hospital admission (aFI) and at his/her discharge (dFI). Patients were followed up to 12 months after the hospital discharge. A statistically significant difference was reported between the aFI (0.31, IQR 0.19-0.44) and the dFI (0.29, IQR 0.19-0.40; p = 0.04). The aFI was directly associated with the risk of in-hospital death (OR = 5.9; 95% CI 2.0-17.5; p = 0.001), 1 year mortality (OR = 5.5, 95% CI 2.4-12.7, p < 0.001) and re-hospitalization (OR = 6.3, 95% CI 2.2-17.9, p = 0.03). Frailty is a strong predictor of negative endpoints in hospitalized older persons. Frailty assessment from routinely collected clinical data may provide important insights about the biological status of the individual and promote the personalization of care.

Sections du résumé

BACKGROUND BACKGROUND
Frailty is a predictor of adverse outcomes in older subjects.
AIMS OBJECTIVE
The aims of this study are to (1) measure the frailty status and its changes occurring during the hospital stay, (2) determine the relationships among frailty and adverse outcomes.
METHODS METHODS
Frailty was assessed using a 46-item Frailty Index (FI) in 156 patients admitted to an Acute Geriatric Medicine Unit. The FI was calculated within 24 h from the hospital admission (aFI) and at his/her discharge (dFI). Patients were followed up to 12 months after the hospital discharge.
RESULTS RESULTS
A statistically significant difference was reported between the aFI (0.31, IQR 0.19-0.44) and the dFI (0.29, IQR 0.19-0.40; p = 0.04). The aFI was directly associated with the risk of in-hospital death (OR = 5.9; 95% CI 2.0-17.5; p = 0.001), 1 year mortality (OR = 5.5, 95% CI 2.4-12.7, p < 0.001) and re-hospitalization (OR = 6.3, 95% CI 2.2-17.9, p = 0.03).
CONCLUSION CONCLUSIONS
Frailty is a strong predictor of negative endpoints in hospitalized older persons.
DISCUSSION CONCLUSIONS
Frailty assessment from routinely collected clinical data may provide important insights about the biological status of the individual and promote the personalization of care.

Identifiants

pubmed: 29946755
doi: 10.1007/s40520-018-0989-7
pii: 10.1007/s40520-018-0989-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

151-155

Auteurs

Giorgio Basile (G)

Unit and School of Geriatrics, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria n. 1, Policlinico pad B, 98125, Messina, Italy. giorgio.basile@unime.it.
Gérontopôle, Centre Hospitalier Universitaire de Toulouse, Toulouse, France. giorgio.basile@unime.it.

Antonino Catalano (A)

Unit and School of Geriatrics, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria n. 1, Policlinico pad B, 98125, Messina, Italy.
Gérontopôle, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Giuseppe Mandraffino (G)

Unit of Internal Medicine, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

Giuseppe Maltese (G)

Unit for Metabolic Medicine, Cardiovascular Division, King's College London, London, UK.

Angela Alibrandi (A)

Department of Economics, University of Messina, Messina, Italy.

Giuliana Ciancio (G)

Unit and School of Geriatrics, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria n. 1, Policlinico pad B, 98125, Messina, Italy.

Daniela Brischetto (D)

Unit and School of Geriatrics, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria n. 1, Policlinico pad B, 98125, Messina, Italy.

Nunziata Morabito (N)

Unit and School of Geriatrics, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria n. 1, Policlinico pad B, 98125, Messina, Italy.

Antonino Lasco (A)

Unit and School of Geriatrics, Department of Clinical and Experimental Medicine, University of Messina, Via Consolare Valeria n. 1, Policlinico pad B, 98125, Messina, Italy.

Matteo Cesari (M)

Gérontopôle, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Université de Toulouse III Paul Sabatier, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH